Literature DB >> 6983379

Metronidazole resistance of Trichomonas vaginalis as a cause of treatment failure in trichomoniasis--A case report.

J Kulda, M Vojtĕchovská, J Tachezy, P Demes, E Kunzová.   

Abstract

Six isolates of a strain (MRP-MT) of Trichomonas vaginalis obtained from a woman before and after unsuccessful treatment with metronidazole had an appreciably lower susceptibility to metronidazole both in vitro in the aerobic tube assay and in vivo in the mouse assay than did control strains from patients cured with standard doses of the drug. Our results support recent evidence that metronidazole-resistant strains of T vaginalis do cause treatment failure. Resistance of these strains could be detected in vitro under only aerobic but not anaerobic conditions. The prevalence of metronidazole-resistant strains of T vaginalis should be kept under surveillance in order to estimate their clinical importance. The patient harbouring the resistant strain MRP-MT was finally cured with increased doses of ornidazole.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6983379      PMCID: PMC1046109          DOI: 10.1136/sti.58.6.394

Source DB:  PubMed          Journal:  Br J Vener Dis        ISSN: 0007-134X


  19 in total

1.  Inactivation of metronidazole by aerobic organisms.

Authors:  D I Edwards; E J Thompson; J Tomusange; D Shanson
Journal:  J Antimicrob Chemother       Date:  1979-05       Impact factor: 5.790

2.  Incomplete anaerobiosis as a cause of metronidazole 'resistance'.

Authors:  S E Milne; E J Stokes; P M Waterworth
Journal:  J Clin Pathol       Date:  1978-10       Impact factor: 3.411

3.  Cross-resistance of Trichomonads to 5-nitroimidazole-derivatives.

Authors:  J G Meingassner; H Mieth
Journal:  Experientia       Date:  1976-02-15

4.  Metronidazole: review of uses and toxicity.

Authors:  F J Roe
Journal:  J Antimicrob Chemother       Date:  1977-05       Impact factor: 5.790

5.  Assay conditions and the demonstration of nitroimidazole resistance in Tritrichomonas foetus.

Authors:  J G Meingassner; H Mieth; R Czok; D G Lindmark; M Müller
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

6.  Uptake of metronidazole and its effect on viability in trichomonads and Entamoeba invadens under anaerobic and aerobic conditions.

Authors:  M Müller; D G Lindmark
Journal:  Antimicrob Agents Chemother       Date:  1976-04       Impact factor: 5.191

7.  Sensitivity of Trichomonas vaginalis to metronidazole, tinidazole, and nifuratel in vitro.

Authors:  B Korner; H K Jensen
Journal:  Br J Vener Dis       Date:  1976-12

8.  Strain of Trichomonas vaginalis resistant to metronidazole and other 5-nitroimidazoles.

Authors:  J G Meingassner; J Thurner
Journal:  Antimicrob Agents Chemother       Date:  1979-02       Impact factor: 5.191

9.  Isolation and properties of metronidazole-resistant mutants of Bacteroides fragilis.

Authors:  M L Britz; R G Wilkinson
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191

10.  Inactivation of metronidazole by anaerobic and aerobic bacteria.

Authors:  E D Ralph; D A Clarke
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

View more
  16 in total

1.  Resistance of Trichomonas vaginalis to metronidazole: report of the first three cases from Finland and optimization of in vitro susceptibility testing under various oxygen concentrations.

Authors:  T Meri; T S Jokiranta; L Suhonen; S Meri
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Alternative pathway of metronidazole activation in Trichomonas vaginalis hydrogenosomes.

Authors:  Ivan Hrdý; Richard Cammack; Pavel Stopka; Jaroslav Kulda; Jan Tachezy
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

3.  The genetic diversity of metronidazole susceptibility in Trichomonas vaginalis clinical isolates in an Egyptian population.

Authors:  Aida A Abdel-Magied; El-Said I El-Kholya; Salwa M Abou El-Khair; Eman S Abdelmegeed; Marwa M Hamoudaa; Sara A Mohamed; Nora Labeeb El-Tantawy
Journal:  Parasitol Res       Date:  2017-09-27       Impact factor: 2.289

4.  The effect of 3-(biphenyl-4-yl)-3-hydoxyquinuclidine (BPQ-OH) and metronidazole on Trichomonas vaginalis: a comparative study.

Authors:  Débora Afonso Silva Rocha; Ivone de Andrade Rosa; Julio A Urbina; Wanderley de Souza; Marlene Benchimol
Journal:  Parasitol Res       Date:  2014-04-22       Impact factor: 2.289

5.  Failure of mebendazole to cure trichomonal vaginitis resistant to metronidazole: case reports.

Authors:  R S Pattman; M S Sprott; A M Kearns; M Earnshaw
Journal:  Genitourin Med       Date:  1989-08

6.  In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis.

Authors:  E M Narcisi; W E Secor
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

7.  Anti-Trichomonas vaginalis monoclonal antibodies inducing complement-dependent cytotoxicity.

Authors:  N Moav; E Draghi; A David; D Gold
Journal:  Immunology       Date:  1988-01       Impact factor: 7.397

8.  Persistent Trichomonas vaginalis infection due to a metronidazole-resistant strain.

Authors:  S Krajden; J G Lossick; E Wilk; J Yang; J S Keystone; K Elliott
Journal:  CMAJ       Date:  1986-06-15       Impact factor: 8.262

9.  Trichomonas vaginalis contact-dependent cytolysis of epithelial cells.

Authors:  Gila Lustig; Christopher M Ryan; W Evan Secor; Patricia J Johnson
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

10.  Evaluation of the effect of miltefosine on Trichomonas vaginalis.

Authors:  Débora Afonso Silva Rocha; Ivone de Andrade Rosa; Wanderley de Souza; Marlene Benchimol
Journal:  Parasitol Res       Date:  2013-12-22       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.